Nyxoah

medical devices

About

Nyxoah is a medical technology company based in Mont-Saint-Guibert, Belgium, focused on developing solutions for Obstructive Sleep Apnea (OSA). Founded in 2009, Nyxoah has expanded globally, with offices in Belgium, Israel, Australia, and the United States, employing around 135 people. The company's flagship product, the Genio® system, is a hypoglossal nerve stimulation therapy that offers a minimally invasive alternative to traditional OSA treatments like CPAP devices. The Genio® system received CE Mark approval in 2019 and achieved FDA PMA approval in August 2025, allowing for its commercialization in the U.S. market. Nyxoah serves patients with moderate to severe OSA and healthcare providers seeking advanced treatment options. The company emphasizes clinical validation and regulatory compliance to enhance patient outcomes worldwide.

Technologies

Mailchimp MandrillRackspace MailGunOutlookAmazon AWSApacheGoogle AnalyticsUbuntuGoogle Tag ManagerMobile FriendlyBootstrap FrameworkreCAPTCHARemote

Keywords

neurostimulation & obstructive sleep apneamedical/dental instrumentshealth caremedical equipment manufacturingminimally invasive implantationhealthcare equipment & suppliestherapy support servicesclinical researchmedical device commercializationsleep disorder treatmentsleep disorder innovationlabel expansionmedical devicespatient supportminimally invasive therapymedical equipment and supplies manufacturinghypoglossal nerve stimulation therapyclinical developmentpatient complianceansa cervicalis stimulationmedical technologymarket expansiondream studyb2bneurostimulationpatient-centered approachgenio systemobstructive sleep apneamedical technology innovationmarket readiness

Location

12 Rue Edouard Belin, Mont-Saint-Guibert, Walloon Region, Belgium, 1435

Related Companies

Companies in the same industry